Overview

IBAT Inhibitor A4250 for Cholestatic Pruritus

Status:
Terminated

Trial end date:
2016-10-01

Target enrollment:

Participant gender:

Summary

This study will evaluate the safety, tolerability and influence on itching, bile acids and liver enzyme changes in patients with PBC (Primary Biliary Cirrhosis) treated with A4250

Phase:

Phase 2

Details

Lead Sponsor:

Sahlgrenska University Hospital, Sweden

Collaborator:

Albireo